vs
Side-by-side financial comparison of Kymera Therapeutics, Inc. (KYMR) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.
Kymera Therapeutics, Inc. is the larger business by last-quarter revenue ($11.5M vs $8.7M, roughly 1.3× SWK Holdings Corp). On growth, SWK Holdings Corp posted the faster year-over-year revenue change (-29.7% vs -55.3%). SWK Holdings Corp produced more free cash flow last quarter ($26.8M vs $-60.6M). Over the past eight quarters, Kymera Therapeutics, Inc.'s revenue compounded faster (10.1% CAGR vs -12.5%).
Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
KYMR vs SWKH — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.5M | $8.7M |
| Net Profit | $-76.6M | $-19.4M |
| Gross Margin | — | — |
| Operating Margin | -736.8% | 9.9% |
| Net Margin | -667.6% | — |
| Revenue YoY | -55.3% | -29.7% |
| Net Profit YoY | -82.1% | -430.2% |
| EPS (diluted) | $-0.95 | $-1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $8.7M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | $11.5M | $10.1M | ||
| Q1 25 | $22.1M | $11.8M | ||
| Q4 24 | $7.4M | $12.4M | ||
| Q3 24 | — | $10.4M | ||
| Q2 24 | $25.6M | $10.8M | ||
| Q1 24 | $10.3M | $11.4M |
| Q4 25 | — | $-19.4M | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | $-76.6M | $3.5M | ||
| Q1 25 | $-65.6M | $4.5M | ||
| Q4 24 | $-70.8M | $5.9M | ||
| Q3 24 | — | $3.5M | ||
| Q2 24 | $-42.1M | $3.7M | ||
| Q1 24 | $-48.6M | $468.0K |
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 61.3% | ||
| Q2 25 | -736.8% | 46.1% | ||
| Q1 25 | -336.8% | 68.6% | ||
| Q4 24 | -1092.2% | 44.7% | ||
| Q3 24 | — | 39.2% | ||
| Q2 24 | -198.5% | 8.3% | ||
| Q1 24 | -562.2% | 9.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 80.7% | ||
| Q2 25 | -667.6% | 35.2% | ||
| Q1 25 | -296.7% | 38.4% | ||
| Q4 24 | -956.9% | 47.5% | ||
| Q3 24 | — | 33.3% | ||
| Q2 24 | -164.0% | 33.9% | ||
| Q1 24 | -472.0% | 4.1% |
| Q4 25 | — | $-1.59 | ||
| Q3 25 | — | $0.72 | ||
| Q2 25 | $-0.95 | $0.29 | ||
| Q1 25 | $-0.82 | $0.37 | ||
| Q4 24 | $-0.89 | $0.47 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | $-0.58 | $0.30 | ||
| Q1 24 | $-0.69 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $335.8M | $42.8M |
| Total DebtLower is stronger | — | $33.0M |
| Stockholders' EquityBook value | $971.5M | $235.1M |
| Total Assets | $1.1B | $272.4M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | $335.8M | $8.0M | ||
| Q1 25 | $90.0M | $29.8M | ||
| Q4 24 | $120.3M | $5.9M | ||
| Q3 24 | — | $17.2M | ||
| Q2 24 | $67.6M | $5.5M | ||
| Q1 24 | $93.5M | $5.5M |
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
| Q4 25 | — | $235.1M | ||
| Q3 25 | — | $254.2M | ||
| Q2 25 | $971.5M | $246.5M | ||
| Q1 25 | $786.2M | $292.7M | ||
| Q4 24 | $835.6M | $288.7M | ||
| Q3 24 | — | $283.4M | ||
| Q2 24 | $684.9M | $282.8M | ||
| Q1 24 | $711.2M | $279.9M |
| Q4 25 | — | $272.4M | ||
| Q3 25 | — | $289.4M | ||
| Q2 25 | $1.1B | $285.7M | ||
| Q1 25 | $918.3M | $331.3M | ||
| Q4 24 | $978.0M | $332.2M | ||
| Q3 24 | — | $321.3M | ||
| Q2 24 | $826.0M | $321.0M | ||
| Q1 24 | $868.3M | $322.0M |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-59.9M | $27.3M |
| Free Cash FlowOCF − Capex | $-60.6M | $26.8M |
| FCF MarginFCF / Revenue | -527.9% | 308.1% |
| Capex IntensityCapex / Revenue | 6.1% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-250.5M | $43.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $27.3M | ||
| Q3 25 | — | $906.0K | ||
| Q2 25 | $-59.9M | $7.8M | ||
| Q1 25 | $-79.2M | $8.3M | ||
| Q4 24 | $-61.8M | $23.0M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | $-42.9M | $5.4M | ||
| Q1 24 | $-39.6M | $4.4M |
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | $-60.6M | $7.7M | ||
| Q1 25 | $-79.6M | $8.2M | ||
| Q4 24 | $-62.7M | $22.9M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | $-47.6M | $5.4M | ||
| Q1 24 | $-47.0M | — |
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | -527.9% | 77.0% | ||
| Q1 25 | -360.3% | 69.1% | ||
| Q4 24 | -848.3% | 185.3% | ||
| Q3 24 | — | 60.4% | ||
| Q2 24 | -185.7% | 49.7% | ||
| Q1 24 | -456.8% | — |
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | 6.1% | 0.6% | ||
| Q1 25 | 2.1% | 0.8% | ||
| Q4 24 | 12.7% | 1.1% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | 18.3% | 0.2% | ||
| Q1 24 | 72.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KYMR
Segment breakdown not available.
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
